Health TrialsbyHealthPanel

The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study

ConditionEctopic Pregnancy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-44
SponsorAssiut University

About this trial

Detect the effect of different treatment modalities of tubal ectopic pregnancy on ovarian reserve

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The study will include patients aged 18-44 years with known diagnosis or suspicion of diagnosis of tubal ectopic pregnancy (abnormal doubling rates of their b-HCG levels as well as ultrasonographically identified or unidentified gestational sacs outside the uterus)

Included patients must have capacity to provide informed consent. Given the potential emergent nature of presentation, women will not be recruited if fully informed consent could be compromised due to a highly distressed emotional state or significant hemorrhage necessitating the need for urgent surgery

Disqualifiers

The use of hormonal contraceptives within two months of enrolment

If other surgery was conducted at the time of salpingectomy.

If a woman was pregnant at follow up visit for AMH measurement

History of previous surgeries of fallopian tubes and/or ovaries

Trial population

Women's Health Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Amh hormone

    Diagnostic test

    Ovarian reserve

Treatment groups

90 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: Conservative management1 intervention
Group B: Medical treatment1 intervention
Group C: Surgical treatment (Open or laparoscopic salpingectomy)1 intervention
Group D: Surgical treatment after failed medical treatment (Open or laparoscopic salpingectomy)1 intervention
Group E: Conservative surgical treatment (salpingotomy, salpingostomy, tubal milking)1 intervention
Group F: Conservative surgical treatment after failed medical treatment1 intervention

Trial outcomes

Primary outcomes

1

Change in levels of AMH pre and post treatment

Time frame
3 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov
Apply now